» Articles » PMID: 33707083

Quality of Life in Cushing's Syndrome

Overview
Publisher Elsevier
Specialty Endocrinology
Date 2021 Mar 12
PMID 33707083
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Measurement of Health-Related Quality of Life (HRQoL) is emerging as an important clinical endpoint which complements diagnostic workup and contributes to place patients at the centre of the decision-making process through the recognition of their needs, concerns, goals and expectations. Chronic excessive cortisol exposure in Cushing's syndrome (CS) causes severe physical and psychological morbidity which invariably affects HRQoL during the active phase of the disease and even after successful treatment. This sustained deterioration of patient's wellbeing is partly related to the persistence of several features associated with prior cortisol excess, including affective disorders, cognitive dysfunctions and negative illness perception. The aim of this review is to summarize the most recent evidence on HRQoL in CS, including the main determinants of its impairment and the results of some educational programs specifically addressed to improve patient's coping abilities. The preliminary results of an unpublished survey on patient's unmet needs will also be presented.

Citing Articles

Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.

Pivonello R, Fleseriu M, Newell-Price J, Shimatsu A, Feelders R, Kadioglu P J Endocrinol Invest. 2024; 47(10):2437-2448.

PMID: 38696122 PMC: 11392997. DOI: 10.1007/s40618-024-02359-6.


Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk.

Valassi E, Manichanh C, Amodru V, Fernandez P, Gaztambide S, Yanez F Front Endocrinol (Lausanne). 2023; 14:1074757.

PMID: 37342265 PMC: 10278540. DOI: 10.3389/fendo.2023.1074757.


Determinants of muscle function and health-related quality of life in patients with endogenous hypercortisolism: a cross-sectional study.

Li D, Zhang C, Saini J, Singh S, Nathani R, Thangamuthu K Eur J Endocrinol. 2023; 188(7):603-612.

PMID: 37327378 PMC: 10376436. DOI: 10.1093/ejendo/lvad069.


Misdiagnosed psychiatric manifestations in a rare disease: a case report of secondary anxiety syndrome in Cushing's disease.

Geng W, Cui L, Li T, Liu X, Yao Y, Hong X Front Psychiatry. 2023; 14:1190899.

PMID: 37181909 PMC: 10174326. DOI: 10.3389/fpsyt.2023.1190899.


Functional brain alterations in Cushing's syndrome.

Papakokkinou E, Ragnarsson O Front Endocrinol (Lausanne). 2023; 14:1163482.

PMID: 37152946 PMC: 10160675. DOI: 10.3389/fendo.2023.1163482.